🇺🇸United States·March 26, 2026·daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 26, 2026

Across 50 filings in the USA S&P 500 Consumer Discretionary stream (broadly including retail, auto, gaming/entertainment proxies), overarching themes reveal mixed financial performance with revenue growth in 6/14 key operational reporters averaging +10% YoY (e.g., Ulta +9.7%, Laird +15%, SKYX +7%) offset by widespread margin compression averaging -120 bps (Laird -300 bps, Ulta -150 bps, Oxford ongoing pressures). Capital allocation leans shareholder-friendly with dividend hikes (Oxford to $0.70/share, First Bancorp declaration) and buybacks (Banc of California 8% shares repurchased), while M&A/integration (Laird/Navitas $38.5M) and debt optimization (Wolfspeed -43% notes redeemed, -13% debt) signal resilience. Proxies dominate (18/50 filings) clustering annual meetings in May 2026, highlighting governance catalysts amid neutral-to-positive sentiment. Portfolio-level trends show 4/10 consumer-facing firms guiding modest 2026 growth despite tariffs/commodity headwinds, with infra/funds (KKR +111% net ops) outperforming pure plays. Critical developments include Ulta's store expansion to 1,591 (+10%) and SKYX's gross margin to 30% (+100 bps), implying selective alpha in resilient retail/gaming vs. broader deterioration in legacy assets.

26 high priority24 medium50 total filings

🇺🇸United States·March 26, 2026·daily

S&P 500 Healthcare Sector SEC Filings — March 26, 2026

Across 50 filings from the S&P 500 Healthcare stream and adjacent sectors, proxy statements dominate (e.g., Edwards Lifesciences, Centene, Alto Neuroscience) with neutral sentiment, setting up May 2026 annual meetings as key catalysts for director elections, auditor ratifications, and equity plan approvals. Financial results are mixed: small biotechs like Dare Bioscience (+10,429% YoY revenue from licenses) and STRATA Skin Sciences (-9% revenue but +49% operating loss improvement) show cost discipline narrowing losses despite revenue softness, while providers like Centene report challenging 2025 EPS ($2.08) but guide >$3.00 for 2026 (+40% YoY growth). Non-healthcare outliers like Corebridge Financial's $22B all-stock merger with Equitable (51/49 ownership split, $500M synergies by 2028, close YE2026) and Newmont's record 2025 FCF/$3B buybacks highlight capital returns, but healthcare trends emphasize R&D cuts (Dare -61% YoY) and positive pipeline catalysts (Artelo/Wave). Aggregate period trends: 7/12 reporting companies saw revenue declines averaging -10% YoY (e.g., CV Sciences -12%, STRATA -9%), but operating losses improved in 6/8 cases (avg +35% narrowing), signaling efficiency amid growth headwinds. Forward-looking optimism in biotech (e.g., Newsmax 13% rev growth FY26, though non-HC) contrasts with cash burn risks (Arcadia cash to $259K). Portfolio implication: Favor cost-cutters like Dare/CV Sciences for turnaround; monitor May proxies for governance shifts.

33 high priority17 medium50 total filings

🇺🇸United States·March 26, 2026·daily

US Executive Compensation Proxy SEC Filings — March 26, 2026

Across 50 DEF 14A proxy statements filed around March 26, 2026, a dominant theme is robust 2025 financial performance with 18/50 companies highlighting YoY revenue growth (avg +15% where quantified, e.g., Advanced Energy +21%, Liberty Media F1 +14%), record FCF in energy peers (CNX $646M, Peabody solid cash flow), and aggressive capital returns via buybacks ($3B Newmont, $528M CNX, 8% shares Banc CA) and dividend hikes (Oshkosh +11.8%, Hanover +5.6%). Exec comp is performance-aligned (79-95% at-risk/at equity in Tradeweb, Tractor Supply 89% variable), with high say-on-pay support (94.2% Eastern Bankshares, but KLX only 44.9%). Mixed signals in healthcare (Centene adj EPS $2.08 below outlook but 2026 >$3.00 +40% growth) and industrials (Oshkosh revenue -2.9% YoY). Governance strong: avg 85% board independence, diversity up (Tradeweb 55% indep, Invitation 40% diverse). No widespread insider selling noted; buybacks signal conviction. Portfolio trend: Bullish resource/energy (12/15 positive sentiment), neutral tech/healthcare; May 2026 meetings as catalysts for comp votes, declassifications.

50 high priority50 total filings

🇺🇸United States·March 26, 2026·daily

US IPO Pipeline SEC S-1 Filings — March 26, 2026

The IPO Pipeline stream shows heightened activity with two newly published SPAC-related filings (Maywood Acquisition Corp. 2 S-1 and Digital Asset Acquisition Corp. S-4) and one operating company IPO (CIMG Inc. S-1), all filed March 25-26, 2026, signaling a potential resurgence in SPAC and traditional IPO markets amid neutral sentiment across the board. Period-over-period data highlights SPAC IPO completions (e.g., Digital Asset's April 30, 2025 IPO) and CIMG's FY2025 financials with Q4 FY2025 trends, but lacks explicit YoY/QoQ growth numbers, focusing instead on structural setups like founder shares and concentrations. Key developments include Maywood's 10M unit IPO structure with 35% founder ownership post-offering, Digital Asset's de-SPAC with Old Glory (agreement Jan 13, 2026), and CIMG's acquisitions (e.g., Braincon Sep 23, 2025) amid customer/supplier concentrations. Portfolio-level patterns reveal standard SPAC dilution risks (founder shares at ~$0.01) and operating co risks from China/North America revenue splits, implying selective opportunities in monitoring IPO progressions. Market implications point to building catalyst calendars around S-1 effectiveness, business combinations, and warrant exercises, with high materiality (9-10/10) underscoring actionable intelligence for early positioning.

3 high priority3 total filings

🇺🇸United States·March 26, 2026·daily

Global High-Priority Regulatory Events — March 26, 2026

Across 50 US SEC filings dated March 26, 2026, focused on global high-priority events, a mixed sentiment prevails with 18 mixed, 8 positive, 7 neutral, and 3 negative, highlighting financial distress (1 bankruptcy, multiple debt restructurings/amendments) juxtaposed against opportunistic financings and narrowing losses in biotechs/small caps. Period-over-period trends show revenue divergence: 12/25 quantifiable 10-K/10-Qs reported YoY declines averaging -7.5% (e.g., Lands' End -2%, NORTECH -7.6%, VirTra -15%), while 13 showed growth averaging +72% (e.g., AmpliTech +165%, Nyxoah +122%, Spero +39%), with margins expanding in 8/15 cases (avg +210 bps, e.g., Lands' End +80 bps, NORTECH +210 bps). Biotech/pharma cluster (10 filings) averaged net loss narrowing 25% YoY amid R&D cuts, but cash burns persisted; retail/apparel saw uniform sales drops (-2% to -5.6%). Capital allocation leans defensive (dividend hikes in Shoe Carnival +11%, Lands' End implied stability; Newmont $3B buybacks), with forward catalysts clustering in May 2026 proxy votes (15+ meetings) and debt/acquisition milestones (Keurig JDE Peet's by Feb 2027). Critical implications: imminent liquidation risks (Broad Street Realty), dilution threats (Sadbhav MRA equity conversions, Wytec warrants), but alpha in turnaround plays (Spero swung to profit) and growth outliers (Paychex +19.8% revenue). Portfolio pattern: monitor small-cap distress vs. large-cap stability for relative outperformance.

50 high priority50 total filings

🇺🇸United States·March 26, 2026·daily

US SEC Trading Suspension Halt Orders — March 26, 2026

Two US-listed companies, FiscalNote Holdings (NOTE) and Cambium Networks (CMBM), faced delisting notices on March 25, 2026, triggering immediate or imminent trading suspensions due to failure to meet exchange listing rules—low average share price for NOTE (below $1.00 over 30 trading days) and non-compliance with prior Nasdaq decision for CMBM. Trading for NOTE (common and warrants NOTE.WS) suspended immediately on NYSE, shifting to OTC Markets on March 26, 2026; CMBM suspension effective March 27 open on Nasdaq, moving to OTCID. No enriched period-over-period financial trends, insider activity, capital allocation, or forward-looking guidance provided in filings, limiting quantitative comparisons, but both exhibit negative sentiment (10/10 materiality) with potential material adverse effects on share price and liquidity. Overarching theme: heightened regulatory pressure on low-priced small-cap stocks, signaling portfolio-level risks in compliance-challenged names. Investors face immediate liquidity and valuation risks, with appeals possible but uncertain outcomes; no impact on operations or SEC reporting noted.

2 high priority2 total filings

🇺🇸United States·March 26, 2026·daily

US Corporate Distress Financial Stress SEC Filings — March 26, 2026

Across 31 filings in the USA Corporate Distress & Bankruptcy stream, dominant themes include aggressive liquidity management through debt amendments/extensions (e.g., WYTEC, Profusa, Diameter Credit), equity raises (Health In Tech $7M PIPE, SmartKem $2.6M), and new credit facilities (Stone Point $250M revolver, Masco $1B), signaling ongoing distress but proactive refinancing amid high interest rates. Outright distress peaks with Broad Street Realty's Chapter 7 bankruptcy liquidation and delistings for FiscalNote (NYSE to OTC) and Cambium Networks (Nasdaq suspension March 27, 2026), while reverse splits (Advantage Solutions 1:25) highlight share price pressures. Period-over-period trends show mixed resilience: Synchrony Card portfolio payment rates up to 24.29% monthly avg in 2026 vs 23.47% in 2025 with 95.1% current accounts; MeiraGTx service revenue -81% YoY but net loss improved 23% to $114.2M. Positive M&A catalysts like OLAPLEX $1.4B sale (55% premium), SSR Mining $1.5B asset sale (Q3 2026 close), and Equitable-Corebridge $22B merger (10% EPS accretion by 2028) offer deleveraging paths. Capital allocation leans toward debt reduction/repayment (Wolfspeed $475.9M refinancing saves $62M annual interest), with no major dividend cuts but dilution risks from warrants/equity. Overall, 7/31 filings indicate severe distress (bankruptcy/delistings), but 15+ show financing successes, implying selective opportunities in refinancings vs high bankruptcy risk in microcaps.

31 high priority31 total filings

🇺🇸United States·March 26, 2026·daily

US Executive Officer Management Changes SEC — March 26, 2026

Across 43 filings on USA executive and director changes from March 26, 2026, the dominant theme is leadership transitions with 22 appointments (experienced hires in energy, tech, banking) versus 18 resignations/departures, mostly neutral sentiment but positive on strategic hires like Vitesse Energy's new CEO and Bloom Energy's CFO. Period-over-period data limited but notable: Interlink Electronics Q4 2025 revenue -4.5% YoY to $2.853M, gross margin -790 bps to 31.7%, though FY revenue +1.8% to $11.89M with net loss improved -19% to -$1.615M. No widespread insider trading or capital allocation shifts, but compensation enhancements (e.g., Meritage Homes CEO target $4M cash +$6M equity, Alight TVR awards up to 8.25M shares) signal retention focus. Positive hires boost conviction in growth sectors like AI/energy (Bloom, 3D Systems), while sudden CFO exits (RetinalGenix, MetroCity) flag risks. Portfolio implication: Monitor energy/utilities (6 filings) for stability, tech/biotech (12 filings) for innovation acceleration; overall neutral-to-positive for long-term value via succession planning.

43 high priority43 total filings

🇺🇸United States·March 26, 2026·daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — March 26, 2026

Broad Street Realty, Inc., the sole filing in this USA Bankruptcy & Insolvency stream, voluntarily petitioned for Chapter 7 bankruptcy on March 20, 2026, in the U.S. Bankruptcy Court for the District of Delaware (Case No. 26-10398-KBO), signaling total liquidation and cessation as a going concern. George L. Miller was appointed Chapter 7 Trustee to oversee asset liquidation and creditor payments, immediately stripping the Board of Directors and executives of all authority. CFO Alexander Topchy resigned effective the same date, underscoring acute management distress amid the collapse. No period-over-period financial trends or forward-looking guidance are viable post-filing, as operations end; sentiment is uniformly negative with 10/10 materiality. This development implies imminent equity wipeout, with portfolio implications for real estate exposure: delisting likely, zero recovery for shareholders. Overarching theme: isolated but extreme insolvency event highlights vulnerability in commercial realty amid presumed prior deteriorating metrics like rising debt or occupancy declines.

1 high priority1 total filings

🇺🇸United States·March 26, 2026·daily

US Corporate Board Director Changes SEC Filings — March 26, 2026

Across 43 filings on USA Board Room Changes from March 26, 2026, the dominant theme is elevated C-suite and board turnover, with 18 CFO/CAO/Principal Accounting Officer changes (e.g., retirements, resignations, appointments), 12 CEO/President shifts, and 15+ board director additions/resignations/not standing for re-election, signaling proactive refreshes amid strategic pivots. Positive sentiment prevails in 12 cases (e.g., experienced hires in energy/tech like Vitesse CEO Jamie Benard, Bloom CFO Simon Edwards), neutral in 26, negative/mixed in 5, with materiality averaging 6/10 and peaking at 9/10 for Vitesse, Apimeds dispute, Skywater transaction. Sparse period-over-period data shows Interlink Electronics Q4 2025 revenue -4.5% YoY ($2.853M vs $2.986M), FY +1.8% ($11.89M), gross margins -780bps Q4/-260bps FY, highlighting product mix pressures; no broad deteriorating trends but isolated losses improving FY net loss -18.6% YoY. Forward-looking catalysts cluster around May 2026 AGMs (Macy's May 15, Auburn May 12) and Q2 transitions (Vitesse May 1 CEO). Portfolio implications: Bullish for leadership upgrades in growth sectors (energy, tech), bearish execution risks in finance CFO churn; monitor for insider conviction via post-change trading.

43 high priority43 total filings

🇺🇸United States·March 26, 2026·daily

US Merger & Acquisition SEC Filings — March 26, 2026

The 8 filings highlight intense SPAC maneuvering amid M&A completions in niche sectors like crypto blockchain and industrial/pharma mergers, with 5/8 filings from blank-check companies (Soulpower, Launch One, Haymaker, IB, Metal Sky) showing extension efforts, financings, and governance changes versus 3 actual deal closures (Atlantic, Crypto Co, Enzon). Key trends include heavy SPAC redemptions (e.g., IB's $7.9M outflow leaving $8.2M trust) and sponsor support via notes/preferred stock, signaling prolonged hunts for targets; no broad YoY/QoQ financial trends reported but capital raises average ~$1.25M principal across notes/preferred for working capital/BC. Positive catalysts emerge from Crypto Co's milestone-based IP acquisition with 2026 blockchain launch and Enzon's all-stock merger (45/55 ownership split), boosting interoperability and operational scale. Mixed sentiment prevails (3 neutral, 2 positive, 1 mixed) with materiality skewed high (5/8 at 7-9/10) on deal-related filings, implying near-term volatility in SPACs but alpha in completed M&A. Portfolio-level pattern: SPACs face redemption pressures (1/5 with quantified $7.9M drain) versus accretive deals with no upfront dilution.

8 high priority8 total filings

🇺🇸United States·March 26, 2026·monthly

US Pre-Market SEC Filings Roundup — March 26, 2026

Across 50 overnight SEC filings for March 25-26, 2026, FY2025 results dominate with mixed outcomes: 12/20 major 10-Ks showed revenue growth averaging +12% YoY (e.g., Lumexa +7.8%, Leef Brands +22.1%, TXO Partners +41.8%), but net losses widened in 8/20 cases amid impairments, higher expenses, and debt costs; REITs and BDCs exhibited portfolio stress with yields declining (BlackRock Multifamily 4.5%, AB Private Credit 9.58% vs 10.51%). SPAC/de-SPAC momentum is strong with 8 filings advancing mergers (Suncrete non-redemptions, Enhanced Games IPO path, Xanadu $500M proceeds), signaling M&A alpha in tech/AI/quantum. Capital allocation leans defensive: buybacks (Williams Sonoma $862M, News Corp $1B program), dividends stable, but leverage rose in energy (TXO +85%). Healthcare/imaging outperforms (Lumexa advanced procedures +14.2% Q4 YoY, leverage down to 3.5x), while banks face NIM expansion offset by provisions (United Security ROA - to 1.01%). Delistings (FiscalNote) and restatements (Genie Energy) flag risks; forward catalysts cluster in Q2 (proxies, earnings April-May). Overall, selective bullishness in growth niches amid broad profitability pressure, favoring de-SPACs and reiterated guidance plays pre-open.

35 high priority15 medium50 total filings

🇺🇸United States·March 25, 2026·daily

S&P 500 Technology Sector SEC Filings — March 25, 2026

Across 25 filings in the USA S&P 500 Technology intelligence stream (despite sector mix including non-tech), proxy statements dominate (12/25) signaling AGM season kickoff with May 2026 meetings, emphasizing governance enhancements like board refreshment at Century Communities and Cadence. Financial results show mixed trends: revenue growth in standouts like Adobe (+12% YoY to $6.4B subscription-driven) and Lafayette Square (+50% investment income to $84.7M), contrasted by declines in Dyadic (-12% YoY revenue) and Planet 13 (-11.2% FY revenue). Capital returns remain robust with $144M buybacks at Century Communities, $2.5B repurchases at Adobe, and $0.25 quarterly dividend at Dime Community. Leadership transitions emerge as a theme in tech-relevant names: Adobe CEO Shantanu Narayen stepping down (search underway), TXN SVP retirement, and Muzinich funds' C-suite overhaul. Period-over-period, 4/7 key financial filers posted YoY revenue growth (avg +17%), but margins mixed with Planet 13 improving to 38.6% yet EBITDA flipping to loss; non-tech outliers like Century Communities highlight operational efficiencies (costs -13k/home). Tech sector implications: Adobe's strength and Micron's debt tender signal balance sheet optimization amid AI/semiconductor cycles, positioning for H2 catalysts.

13 high priority12 medium25 total filings

🇺🇸United States·March 25, 2026·daily

Nasdaq 100 Stocks SEC Filings — March 25, 2026

Across 20 NASDAQ-100 related SEC filings from March 25, 2026, key themes include robust capital returns via dividends and buybacks (e.g., Century Communities $178.4M dividends + $144M repurchases, Adobe $2.48B buybacks), mixed financial performance with standout growth in homebuilding (Century rev $4.1B) and software (Adobe +12% YoY rev to $6.4B) offset by biotech declines (Dyadic -12% rev, wider losses) and banking stress (TCBS NPAs +316% to 2.65%). Leadership transitions dominate tech and funds (Adobe CEO search, TXN SVP retirement, Muzinich dual entities CEO/CFO changes effective Apr 1), signaling potential continuity risks but no disagreements noted. Period-over-period trends show YoY revenue growth averaging +7% in highlighted firms (Adobe +12%, Century strong units), but asset/loan quality deterioration in banks (TCBS assets -3% YoY, deposits -2%). Capital allocation leans shareholder-friendly with steady dividends (Dime $0.25, CMC $0.20), while debt actions (Micron tenders, OneMeta $2.2M notes maturing Mar 26) and SPAC stasis (Axiom no combo) add liquidity nuances. Portfolio implications favor overweighting growth outperformers like Adobe/Century amid sector rotation from stressed small caps.

11 high priority9 medium20 total filings

🇺🇸United States·March 25, 2026·daily

S&P 500 Financials Sector SEC Filings — March 25, 2026

Across 50 SEC filings from S&P 500 Financials and related entities dated March 25, 2026, overarching themes include resilient revenue growth in select tech-adjacent financial services (avg 16% YoY in Pure Storage, UiPath, Braze) offset by margin compression (avg -100bps in Rentokil, Braze, Spectral AI) and persistent SPAC challenges with high redemptions eroding trust balances (e.g., Concord -99.6%, byNordic -53%). Capital allocation leans shareholder-friendly with dividend hikes (Zedge +25% to $0.02/share), buybacks (News Corp $1B program, Chiba Bank ¥14.5B preferred repurchase), and M&A activity (Sandisk $1B Nanya stake at 15% discount, Thermon/CECO merger synergies). Mixed sentiment prevails (28/50 mixed/neutral), with positive signals from profitability turnarounds (UiPath $282M net income vs prior loss) and forward catalysts like AGMs (NOVAGOLD May 14), liquidations (Stratus $29.73-$37.69/share), and Phase 2 trials (Maze Therapeutics mid-2026). Portfolio-level trends show 12/20 revenue reporters growing >10% YoY but 8/15 loss-makers widening deficits amid high opEx (avg +20% in Pure, Braze). Key implications: Favor growth names with cash buffers (Chewy $860M cash, Energous $39.4M post-raise) over liquidity-strapped SPACs; monitor Q2 catalysts for alpha.

31 high priority19 medium50 total filings

🇺🇸United States·March 25, 2026·daily

S&P 500 Consumer Staples Sector SEC Filings — March 25, 2026

Across 50 filings in the USA S&P 500 Consumer Staples intelligence stream (broadly encompassing food, beverages, household, and related sectors amid mixed filings), overarching themes include modest revenue growth in select REITs and producers (avg +1-15% YoY in AFFO/revenues for Modiv/Global Self/Fresh Del Monte), robust M&A activity (e.g., Fresh Del Monte's $285M Del Monte assets acquisition), stable dividend declarations (Armour $0.24/share, Global Self $0.0725/qtr), and neutral compliance-heavy trust/SPAC reports dominating volume. Period-over-period trends show mixed results: AFFO/FFO growth (Modiv +15.1% YoY, Global Self +3.4%) offset by net income declines (Modiv -91.5%, Global Self -4%) and impairments, with Consumer Staples standouts like Fresh Del Monte and Hershey showing expansion via deals/proxies. Critical developments include positive merger synergies (Thermon/CECO), FDA priority review (Celcuity PDUFA Jul 17, 2026), and NYSE delisting risks (SelectQuote), implying sector resilience in branded foods amid macro pressures but vigilance on REIT-like exposures misaligned with staples. Portfolio-level patterns reveal 4/10 key filings with YoY revenue/NOI stability (+0.6-1.4%), dividend commitment signaling conviction, and upcoming catalysts in meetings/M&A closings driving near-term alpha.

30 high priority20 medium50 total filings

🇺🇸United States·March 25, 2026·daily

S&P 500 Industrials Sector SEC Filings — March 25, 2026

Across the 50 filings in the USA S&P 500 Industrials intelligence stream (broadly encompassing aerospace, defense, machinery, transportation, construction, and adjacent sectors), sentiment is mixed with 14 positive, 16 mixed, and 20 neutral/bearish outcomes, highlighting revenue resilience in select industrials (Winnebago +6% QoQ, Generac $4.2B FY sales) amid broader challenges in adjacent biotech/pharma and financials. Key period-over-period trends include revenue growth averaging +12% YoY in growth outperformers (Pure Storage +16%, Local Bounti +27%, ECB Bancorp NII +29%), but persistent net losses in biotech (Kiora -$10.8M vs +$3.6M prior, Armata -$173M), margin pressures (Pure Storage opex +17-20%), and asset quality deterioration (Texas Community NPA +316%). Critical developments feature M&A momentum (Fresh Del Monte $285M acquisition, Merck/Terns $6.7B at 31% premium), dividend hikes signaling confidence (Zedge +25% to $0.02, Parke $0.18), and SPAC trust balances exceeding $230M (Aldel $243M, Range $232M). Capital allocation favors returns (3M $4.8B dividends/buybacks, Armour $0.24 monthly div), with forward catalysts clustered in May 2026 proxy meetings and Q2-Q3 pharma readouts. Portfolio-level patterns show industrials/transport outperforming (e.g., Winnebago profitable turnaround) versus biotech drags, implying selective rotation into revenue growers with strong balance sheets.

32 high priority18 medium50 total filings

🇺🇸United States·March 25, 2026·daily

S&P 500 Energy Sector SEC Filings — March 25, 2026

Across the 7 filings in the USA S&P 500 Energy stream, dominant themes include neutral governance updates (board retirements at ONEOK, bylaws amendments at Chevron, proxy solicitations at Chesapeake Utilities) with low-to-moderate materiality, contrasted by mixed sentiment in non-core IPO registrations (AsiaPac AdTechinno, Texxon Holding) highlighting controlled company structures and growth funding needs. Kaanapali Land's 10-K reveals deteriorating financials with net loss widening to $3.7M (-236% YoY from $1.1M), revenues down 16% YoY to $1.6M, cash -32% to $15.8M, and operating cash use doubling to $5.9M, marking a clear underperformer. No insider trading activity reported across filings; capital allocation shows stable distributions at Kaanapali ($0.9M in 2025 vs $0.8M prior). Forward-looking catalysts cluster in Q2 2026: annual meetings (ONEOK May 20, CPK May 6), Texxon trial production April 2026, and pending IPOs. Portfolio-level trends limited by sparse metrics, but Kaanapali's margin improvements via 26% YoY op ex cut signal cost discipline amid revenue weakness. Overall neutral sector tone implies low volatility, with alpha in monitoring governance transitions and IPO dilutions risks.

5 high priority2 medium7 total filings

🇺🇸United States·March 25, 2026·daily

US Material Events SEC 8-K Filings — March 25, 2026

Across 50 SEC 8-K filings from March 25, 2026, dominant themes include widespread board and executive transitions (24 instances of appointments, resignations, retirements across firms like Brand Engagement, Ingredion, HBT Financial, Comstock, Conduent, etc.), signaling proactive governance refreshes amid strategic pivots; robust debt management with 8 credit amendments/extensions (Cipher Mining, Synergy CHC, Senior Credit, Waste Management, Albemarle) enhancing liquidity; active M&A and asset transactions (Sandisk $1B Nanya stake, Fresh Del Monte $285M acquisition, Terns $6.7B Merck buyout, Hecla $160M mine sale); and financings (Apogee $377M equity, Blue Water $125M SPAC IPO, Ballston Spa $26M notes). Period-over-period trends are sparse but notable: Maze Therapeutics cash runway extended 83% YoY to $360M (runway to 2028) despite net loss widening to $131.1M from $52.2M profit (R&D +30% YoY, G&A +31%); CIMG Q1 FY2026 revenue exploded to $15.8M from $23k YoY (+69,000%); Generac FY2025 sales $4.2B with Residential EBITDA $558M. Positive sentiment prevails (28/50 filings), especially biotech/pharma (Maze Phase 2 success, Terns M&A) and energy/mining deleveraging; portfolio implications favor monitoring biotech catalysts and governance-improved names for alpha, while watching leadership vacuums and mixed financials like Maze/CIMG delisting risks.

50 high priority50 total filings

🇺🇸United States·March 25, 2026·daily

Dow Jones 30 Stocks SEC Filings — March 25, 2026

Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (period March 25, 2026), mixed financial results dominate with 12/20 10-K/10-Q filings showing revenue/AFFO growth (avg +12% YoY) offset by net income declines (avg -45% YoY) due to impairments and one-offs in REITs and industrials. Positive catalysts include raised guidance (e.g., Karman +53% revenue), M&A synergies (Thermon/CECO), and capital returns ($4.8B at 3M, $500M+ at Enact), while proxy season ramps up with 15+ AGMs in May 2026 featuring stock splits, say-on-pay, and director elections. REITs like Modiv (+15% AFFO) and Global Self Storage (+1.4% revenue, 93% occupancy) highlight operational resilience amid asset sales, but banks face nonperforming asset spikes (e.g., Texas Comm +316%). Overall sentiment skews mixed/neutral (28/50), with bullish outliers in growth sectors (space/defense, pharma) signaling portfolio rotation opportunities. Key implications: Favor companies with strong backlogs/guidance over those with impairments; monitor May catalysts for governance shifts and capital allocation updates.

29 high priority21 medium50 total filings